{
  "url": "https://openlegislation.uk/national-health-service-primary-medical-services-miscellaneous-amendments-and-transitional-provisions-regulations-2013/regulation-54",
  "json_url": "https://openlegislation.uk/national-health-service-primary-medical-services-miscellaneous-amendments-and-transitional-provisions-regulations-2013/regulation-54.json",
  "legislation": "uksi/2013/363",
  "legislation_title": "The National Health Service (Primary Medical Services) (Miscellaneous Amendments and Transitional Provisions) Regulations 2013",
  "legislation_url": "https://openlegislation.uk/national-health-service-primary-medical-services-miscellaneous-amendments-and-transitional-provisions-regulations-2013",
  "path": "regulation/54",
  "kind": "regulation",
  "number": "54",
  "heading": "National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004",
  "text": "(1) The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 are amended as follows.\n(2) In Schedule 2 (drugs, medicines and other substances that may be ordered only in certain circumstances)—\n(a) in column 1, omit the entry for “Cyanocobalamin Tablets” and the adjacent part which relates to the description of the patient (column 2) and the specified purpose (column 3);\n(b) for the entry for “Oseltamivir (Tamiflu)” which is referred to in column 1, in the part which relates to the description of the patient (as mentioned in column 2), in paragraph (1A) and (2A), for “are part of a Primary Care Trust’s antivirals distribution service.”, substitute “are part of an antiviral distribution service provided by the Board, Public Health England or a Local Authority.”; and\n(c) for the entry for “Zanamivir (Relenza)” which is referred to in column 1, in the part which relates to “patient” (as mentioned in column 2), in paragraph (2) for “are part of a Primary Care Trust’s antivirals distribution service.”, substitute “are part of an antiviral distribution service provided by the Board, Public Health England or a Local Authority.”.",
  "extent": "E+W",
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "I",
      "label": "I1",
      "text": "Reg. 54 in force at 1.4.2013, see reg. 1(1)"
    },
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2004/629. Relevant amending instruments are S.I. 2004/3215, 2009/2230, 2010/2389 and 2011/680 and 1043."
    },
    {
      "type": "footnote",
      "label": "f2",
      "text": "Public Health England is an Executive Agency of the Department of Health."
    }
  ],
  "outstanding_effects": [],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2013/363/regulation/54",
    "retrieved_at": "2026-10-29T01:03:46.382083+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}